Zai Lab Limited (NASDAQ:ZLAB) and INSYS Therapeutics Inc. (NASDAQ:INSY) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation.
Valuation and Earnings
Table 1 highlights Zai Lab Limited and INSYS Therapeutics Inc.’s gross revenue, earnings per share and valuation.
Table 2 provides us the return on equity, return on assets and net margins of both companies.
Zai Lab Limited’s Current Ratio and Quick Ratio are 17.8 and 17.8 respectively. The Current Ratio and Quick Ratio of its competitor INSYS Therapeutics Inc. are 0.7 and 0.6 respectively. Zai Lab Limited therefore has a better chance of paying off short and long-term obligations compared to INSYS Therapeutics Inc.
The table shown features the ratings and recommendations for Zai Lab Limited and INSYS Therapeutics Inc.
INSYS Therapeutics Inc. on the other hand boasts of